Role of Macrophage Migration Inhibitory Factor (MIF) in Pneumococcal Pathogenesis

巨噬细胞迁移抑制因子 (MIF) 在肺炎球菌发病机制中的作用

基本信息

  • 批准号:
    8224136
  • 负责人:
  • 金额:
    $ 13.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-30 至 2015-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Despite the use of antibiotics and vaccines, Streptococcus pneumoniae (pneumococcus) remains a leading cause of community acquired pneumonia and mortality. Pneumococcal strains are maintained in the population as commensal colonizers of the mucosal surfaces of the upper respiratory tract (URT), which is a precursor to infection of the lower respiratory tract (LRT). Research to date indicates that the pneumococcus has a variety of interactions with the host immune system that are dictated by bacterial as well as host factors, and the anatomical location of the interface. Host factors that lead to the clearance of the bacterium from its commensal niche on the mucosal surface of URT are not well defined. Moreover, it is often the exuberance of the host inflammatory response that leads to morbidity and mortality in the case of invasive pneumococcal infection in the LRT. My preliminary data demonstrate an important role for macrophage migration inhibitory factor (MIF), a cytokine and upstream mediator of the innate immune response, in pneumococcal infection. In a model of nasal colonization with the organism, I have shown that MIF-deficient mice have a prominent defect in the ability to clear URT pneumococcal colonization. In contrast, MIF seems to play a detrimental role in murine LRT infection with pneumococcus. I have demonstrated that presence of MIF in this model is associated with increased local cytokine production and neutrophil influx, resulting in lung tissue destruction, bacterial dissemination, and greater mortality. My hypothesis for this K08 proposal is that MIF has a dual role in pneumococcal pathogenesis - it is necessary for macrophage mediated clearance of URT colonization, but also promotes inflammatory tissue damage in response to invasive infection in the LRT. In Aim#1, I will investigate the mechanism by which MIF promotes clearance of pneumococcal colonization in the URT by examining the role of MIF in macrophage recruitment, activation, and function. In Aim#2, I will explore the contribution of MIF to pathogenic neutrophil recruitment and activation in the LRT. At Yale, I began my training in research methodology and innate immunity to infectious pathogens as a PhD candidate as well as an infectious disease fellow in the laboratory of Dr. Richard Bucala, who serves as my co-mentor for this proposal. Now as a post-doctoral researcher at the University of Pennsylvania, with Dr. Jeffrey Weiser as my primary mentor, I plan to examine the mechanisms by which the immune system interacts with pneumococcus from colonization to disease. I have assembled a mentorship committee as well as a program of training throughout the course of this proposal that will serve as the basis for my career as an independent investigator examining the role of innate immunity in host-pathogen interactions. Pneumococcal disease remains a major cause of morbidity and mortality across the spectrum of age. Understanding the interaction between the immune system with the bacterium will allow us to appreciate how pneumococcus exists as a colonizer in the nasal mucosa but causes destructive invasive disease in the lungs. My work on the role of the host cytokine, macrophage migration inhibitory factor in both colonization and disease with the pathogen may lead to novel vaccination strategies, immune modulating therapies, or identification of patients at greatest risk for severe pneumococcal disease.
描述(由申请人提供):尽管使用了抗生素和疫苗,但肺炎链球菌(肺炎球菌)仍然是社区获得性肺炎和死亡率的主要原因。肺炎球菌菌株在人群中作为上呼吸道(URT)粘膜表面的共生定植菌维持,这是下呼吸道(LRT)感染的前兆。迄今为止的研究表明,肺炎球菌与宿主免疫系统有多种相互作用,这些相互作用由细菌和宿主因素以及界面的解剖位置决定。导致细菌从上呼吸道粘膜表面共生生态位清除的宿主因素尚未明确。此外,在LRT侵袭性肺炎球菌感染的情况下,往往是宿主炎症反应的旺盛导致发病率和死亡率。我的初步数据表明,巨噬细胞迁移抑制因子(MIF),一种细胞因子和先天免疫反应的上游介质,在肺炎球菌感染中发挥重要作用。在有机体的鼻腔定植模型中,我已经证明,mif缺陷的小鼠在清除上呼吸道肺炎球菌定植的能力方面存在显著缺陷。相反,MIF似乎在小鼠肺炎球菌LRT感染中起有害作用。我已经证明,在这个模型中,MIF的存在与局部细胞因子产生和中性粒细胞流入增加有关,导致肺组织破坏、细菌传播和更高的死亡率。我对K08提案的假设是,MIF在肺炎球菌的发病机制中具有双重作用——它是巨噬细胞介导的上呼吸道定植清除所必需的,但在上呼吸道侵袭性感染的反应中,它也促进炎症组织损伤。在Aim#1中,我将通过检查MIF在巨噬细胞募集、激活和功能中的作用来研究MIF促进上呼吸道肺炎球菌定植清除的机制。在Aim#2中,我将探讨MIF对LRT中致病性中性粒细胞募集和激活的贡献。在耶鲁大学,我开始学习研究方法和对感染性病原体的先天免疫作为博士候选人,同时也是Richard Bucala博士实验室的传染病研究员,他是我的共同导师。现在,作为宾夕法尼亚大学的博士后研究员,Jeffrey Weiser博士是我的主要导师,我计划研究免疫系统与肺炎球菌从定植到发病的相互作用机制。我已经组建了一个指导委员会,并在整个提案过程中制定了一个培训计划,这将成为我作为一名独立调查员的职业生涯的基础,研究先天免疫在宿主-病原体相互作用中的作用。肺炎球菌病仍然是各年龄段发病率和死亡率的主要原因。了解免疫系统与细菌之间的相互作用将使我们了解肺炎球菌如何作为鼻黏膜的定植者存在,但却导致肺部的破坏性侵袭性疾病。我对宿主细胞因子、巨噬细胞迁移抑制因子在病原体定植和疾病中的作用的研究可能会导致新的疫苗接种策略、免疫调节疗法或识别严重肺炎球菌疾病风险最高的患者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rituparna Das其他文献

Rituparna Das的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rituparna Das', 18)}}的其他基金

Role of Macrophage Migration Inhibitory Factor (MIF) in Pneumococcal Pathogenesis
巨噬细胞迁移抑制因子 (MIF) 在肺炎球菌发病机制中的作用
  • 批准号:
    8339920
  • 财政年份:
    2011
  • 资助金额:
    $ 13.38万
  • 项目类别:
Role of Macrophage Migration Inhibitory Factor (MIF) in the Pathogenesis of Tuber
巨噬细胞迁移抑制因子(MIF)在块茎发病机制中的作用
  • 批准号:
    8002665
  • 财政年份:
    2011
  • 资助金额:
    $ 13.38万
  • 项目类别:
Role of Macrophage Migration Inhibitory Factor (MIF) in Pneumococcal Pathogenesis
巨噬细胞迁移抑制因子 (MIF) 在肺炎球菌发病机制中的作用
  • 批准号:
    8528463
  • 财政年份:
    2011
  • 资助金额:
    $ 13.38万
  • 项目类别:
Role of Macrophage Migration Inhibitory Factor (MIF) in Pneumococcal Pathogenesis
巨噬细胞迁移抑制因子 (MIF) 在肺炎球菌发病机制中的作用
  • 批准号:
    8712348
  • 财政年份:
    2011
  • 资助金额:
    $ 13.38万
  • 项目类别:

相似海外基金

DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
  • 批准号:
    EP/Y023528/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.38万
  • 项目类别:
    Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
  • 批准号:
    BB/Y007611/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.38万
  • 项目类别:
    Research Grant
Hitting bacteria with a Bam: Lectin-Like Antimicrobials as New Antibiotics
用 Bam 击中细菌:凝集素类抗菌剂作为新型抗生素
  • 批准号:
    DP230102150
  • 财政年份:
    2023
  • 资助金额:
    $ 13.38万
  • 项目类别:
    Discovery Projects
Systematic identification of synthetic interactions in bacteria towards the next-generation of antibiotics
系统鉴定细菌与下一代抗生素的合成相互作用
  • 批准号:
    468567
  • 财政年份:
    2022
  • 资助金额:
    $ 13.38万
  • 项目类别:
    Operating Grants
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
  • 批准号:
    FL210100071
  • 财政年份:
    2022
  • 资助金额:
    $ 13.38万
  • 项目类别:
    Australian Laureate Fellowships
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
  • 批准号:
    10708102
  • 财政年份:
    2022
  • 资助金额:
    $ 13.38万
  • 项目类别:
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
  • 批准号:
    10587015
  • 财政年份:
    2022
  • 资助金额:
    $ 13.38万
  • 项目类别:
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
  • 批准号:
    10581945
  • 财政年份:
    2021
  • 资助金额:
    $ 13.38万
  • 项目类别:
Developing novel antibiotics from natural products against resistant bacteria
从天然产物中开发针对耐药细菌的新型抗生素
  • 批准号:
    2599490
  • 财政年份:
    2021
  • 资助金额:
    $ 13.38万
  • 项目类别:
    Studentship
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
  • 批准号:
    10358855
  • 财政年份:
    2021
  • 资助金额:
    $ 13.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了